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EDITORIAL
The liver can be the target of various dis-eases, with result ing physiologicalchanges that compromise the general
functioning of the organism, with a possible fatal out-
come for the patient. Hepatic diseases of current high
clinical interest are: hepatocellular carcinoma, cirrho-
sis, cholestasis, and steatosis. In cases of irreversible
involvement of the organ, a liver transplant may be the
only treatment alternative.
In a reasonable number of cases, the diagnosis
of hepatic injuries is made by histopathological analy-
sis of a tissue sample collected with a biopsy after tis-
sue processing. The cellular and tissue changes com-
pared to normal tissue are used by pathologists as
parameters for the classification and discrimination of
tissues. Conventional histopathological analysis cannot
be performed in situ or in real time since it requires
previous tissue processing.
Cirrhosis is a general denomination for the final
and irreversible stage of various chronic liver diseases
of distinct etiologies, representing one of main casuses
of death not associated with neoplasias in the Western
world. The more common etiologis of cirrhosis of the
liver are alcoholism, viral hepatites and chronic changes
of the biliary tree. Morphologically, cirrhosis of the liver
is defined by the presence of fibrous septa that diffusely
involve the liver and subdivide the parenchyma, with the
formation of structurally abnormal regeneration nodules,
complete alteration of architecture with spatial changes
of the portal tract and hepatic veins and obliteration of
small hepatic veins that are incorporated into venoportal
septa. Its morphological diagnosis by means of a liver
biopsy can be defined as diffuse scarring of the liver
characterized by the loss of lobular architecture. Pro-
gressive fibrosis is the central characteristic of cirrho-
sis and, from a pathogenetic viewpoint, cirrhosis reflects
the complex of superimposition of fibrosis and of hepa-
tocyte regeneration due to to inflammation and to
chronic parenchymatous injury, which is the basis of
most of the complications occurring in the last stages
of chronic hepatic diseases. A consequence of this struc-
tural derangement is the inherent irreversibility of cir-
rhosis.
During the process of hepatic cirrhosis, fibrosis
is representaed by connective tissue that separates the
liver into multiple nodules. The fibrous septa vary con-
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siderably from delicate to extensive, often containing
inflammatory cells and varying numbers of arterial,
venous and biliary structures. In cases of well-estab-
lished cirrhosis, fibrosis completely surrounds the nod-
ules, although there are cases of incomplete septal
cirrhosis with partial involvement of the regeneration
nodules.
Regenerative hepatocyte hyperplasia is seen as
an attempt to restore the integrity of the parenchyma,
contributing to the formation of nodules and to the in-
creased disorganization of cirrhosis. Despite its notori-
ety, the proliferative capacity of the hepatocytes is poorly
understood and the mechanisms responsible have been
intensively explored, with the regulation of normal hepa-
tocyte growth being controlled by various growth fac-
tors.
The main complications of cirrhosis (hepatic in-
sufficiency, portal hypertension and hepatocellular car-
cinoma) occur in the advanced and decompensated
form of the condition.
Hepatocellular carcinoma (HCC) represents 80
to 90% of primary liver neoplasias and about 10% of
systemic neoplasias. It occurs almost exclusively in
patients with chronic liver diseases, in 90% of cases in
livers in the phase of cirrhosis. The  prevalence of the
tumor in cirrhosis of the liver is sufficiently high to jus-
tify periodic and meticulous follow-up of cirrhotic pa-
tients. There are various mechanisms of liver carcino-
genesis which are interrelated, synergic and still in-
completely understood. They include specific processes
such as indirect etiologic agent-hepatocyte interaction,
genetic pathways as well as cirrhosis per se, a cyclic-
progressive condition of inflammation-regeneration-fi-
brosis that includes dysplastic nodules. However, only
15 to 20% of patients with HCC benefit from poten-
tially radical therapeutic options such as resection, liver
transplantation and tumor alcoholization, with surgical
indications being extremely judicious, especially in cir-
rhotic patients whose functional hepatic reserve is the
main limiting factor regarding liver interventions.
Liver resection and transplantation currently
represent the surgical treatments most frequently used,
with safe benefits for patients with HCC. Hepatic re-
section is an operation whose success depends on the
regenerative capacity of the liver. The methods de-
scribed for patient selection are functional evaluation
and tumor staging.
Evaluation and selection are necessary due to
the reductions of the regenerative capacity of the liver
and to the degree of functional reserve typical of liver
disease which, if not considered, may trigger signs and
symptoms of postoperative hepatic insufficiency fol-
lowed by multiple organ failure. Hepatic resection
should be the minimum effective one corresponding to
accepted oncology principles and should include the
portal unit on which the tumor rests, this being one of
the major pathways of tumor dissemination. Postop-
erative mortality is related to three factors: extension
of resection, functional capacity of the remnant liver
and serious vascular injuries.
Considering the standard techniques for the di-
agnosis and treatment of liver diseases and their limi-
tations, there is great interest in the development of
new technologies and of new merthods to improve the
current conditions detected. The new optic technolo-
gies have a high potential of incorporation into clinical
principles of diagnosis and treatment in view of their
principles of action and their operating characteris-
tics. One of the most important properties is the possi-
bility of selective interaction of laser light with a spe-
cific molecule or compound within a system full of other
types of molecules, as is the case for biological tis-
sues. The applications of optic techniques in medicine
include: the use of laser as a surgical cutting and abla-
tion instrument, phototherapy for the biomodulation of
cell responses, optic diagnosis based on fluorescence
and reactance, and photodynamic therapy for tumor
treatment and microbial control. These techniques are
being investigated and applied in different medical
specialties. Fluorescence-based diagnosis is one of the
main optic techniques for the detection of varied types
of cancer. Laser-induced fluorescence of the target
tissue investigated depends on the constituent bio-
chemical and structural characteristics, with a normal
tissue emitting a different fluorescence compared to
neoplastic tissue. The fluorescence spectrum can be
collected on the surface of the tumor and the informa-
tion is obtained by a noninvasive and non-destructive
procedure. After the determination of the spectral iden-
tities and of the appropriate processing for each type
of disease investigated, in the specific case of the
present project: cirrhosis, steatosis and HCC, the re-
sponse can be obtained in real time. Experimental stud-
ies conducted on animal models by our group have
demonstrated the sensitivity of the technique in dis-
criminating between mild, moderate and severe stea-
tosis and in the evaluation of the viability of the hepatic
graft for transplant purposes. The spectral changes
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observed in these two examples were confirmed by bio-
chemical exams and by the evaluation of hepatic func-
tion, based on the amount of fat extracted from the
liver in the case of steatosis, and by the evaluation of
mitochondrial respiration at different times of graft in-
vestigation
Considerably attractive applications of optic di-
agnosis are: detection of HCC, cirrhosis, steatosis and
metastatics lesions in the liver; delimitation of the mar-
gins of the lesions; evaluation of the viability of the he-
patic graft without and with varying levels of steatosis;
evaluation of hepatic ischemia and reperfusion; evalu-
ation of the quality of cold pergfusion and of reperfusion
in livers to be transplanted.
Photodynamic therapy is a type of photochemo-
therapy based on the action of a photosensitizer, of
light and of cellular oxygen. Tumor treatment is per-
formed with a photosensitizer with selective interac-
tion with neoplastic tissues which, after photoactivation,
promotes the formation of highly reactive and oxidant
compounds, the most important being singlet oxygen.
As a response, the induction of tumor death mainly
occurs by membrane lysis, damage to or inactivation
of mitochondrial function, and vascular damage. The
choice treatment for HCC is surgical resection, with
the reestablishment of hepatic function depending on
the quality and quantity of the remnant organ. In some
cases hepatic resection is impossible due to the exten-
sion of the tumor which prevents the reestablishment
of hepatic functions, with no treatment alternative.
Photodynamic therapy may represent an alternative for
tumor reduction, improving patient condition or even
permitting a later resection of a reduced tumor mass.
There still is no clinical protocol for photodynamic
therapy for the treatment of hepatic tumors. Studies,
some of them still to be designed, will be conducted in
order to determine therapy parameters such as form
of administration and more adequate type of photo-
sensitizer, interval between administration and illumi-
nation, and light dosimetry. Studies to be carried out
in a rat model of HCC will emphasize the optic charac-
terization of the tumor, the distribution and indirect
quantitation of the photosensitizer, and induced necro-
sis as a function of different illumination parameters
such as fluency (energy dose), irradiance, time of irra-
diation and light coupling geometry.
Both regarding hepatic resection and liver trans-
plantation, in a pilot project we have performed func-
tional hepatic evaluation. This evaluation has been per-
formed by laser-induced fluorescence and based on
the mitochondrial function of the liver in an attempt to
assess the functional hepatic capacity of the liver rem-
nant in cases of partial hepatic resection, and of liver
vitality in transplants. For the diagnosis of hepatic
tumors, from an experimental viewpoint it is necessary
to induce experimental hepatocarcinomas in rats. Re-
garding the evaluation of hepatocellular function in liver
transplantation, the study has been conducted on pa-
tients submitted to liver transplantation and their re-
spective donors in the Clinical Transplant Program of
the University Hospital, Faculty of Medicine of Ribeirão
Preto, USP.
On this basis, reviews and viewpoints regarding
the above topics are being prepared by several authors
in order to be published, after due approval, in our
journal in 2012, taking advantage of the process or
regularization of publication of Revista Medicina,
Ribeirão Preto.
